Drug profile · INN
amikacin
ARIKAYCE LIPOSOMAL
amikacin (ARIKAYCE LIPOSOMAL) is an FDA-listed pharmaceutical active ingredient.
EMA: approved Antiinfectives for systemic use (J01) J01GB06
Patents linked 0
Pipeline programs 34
News articles 0
Drug details — amikacin
- Class
- Antiinfectives for systemic use (J01)
- Route
- —
- Patents
- 0
- Programs
- 34
- Data quality
- 0.83
Quick answer
amikacin (ARIKAYCE LIPOSOMAL) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN amikacin
Brand ARIKAYCE LIPOSOMAL
Therapeutic class Antiinfectives for systemic use (J01)
ATC code J01GB06
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is amikacin?
amikacin (ARIKAYCE LIPOSOMAL) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for amikacin?
ARIKAYCE LIPOSOMAL is a marketed brand name for amikacin. Check FDA Drugs@FDA for the current US label holder and prescribing information.